Public consultation results on draft Project Plan on “Biodegradable stents for benign refractory esophageal stenosis”
This document presents the result of the public consultation on the the WP5 Strand B draft Project Plan on “Biodegradable stents for benign refractory esophageal stenosis”. draft_project_plan_replies_public_consultation_biodegradable_stents_20140710.pdf
Public consultation results on draft Project Plan on ‘Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction
This document presents the result of the public consultation on the the WP5 Strand B draft Project Plan on “Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction” Draft Project Plan on _Balloon Eustachian tuboplasty_public consultation results_20140710.pdf
Responses to Public consultation of the draft Project Plan on Endobarrier
The draft Project Plan on “Duodenal-jejunal bypass sleeve (Endobarrier®) for the treatment of obesity” was open to public consultation between 21 March and 4 April 2013. This document presents the comments through the public consultation. The aim of the Project Plan is to provide an overview on the planned processes, the scope, the scientific methods […]
Review phase comments and authors’ replies on second pilot rapid assessment on “Renal denervation systems for treatment-resistant hypertension”
Find the summary document of comments and authors’ replies of the review of the 2nd draft version of the pilot assessment attached at the bottom of this page. You can find the second pilot rapid assessment here – and the project plan of the pilot here. WP5 Strand B_2nd pilot_Comments tables
Second pilot rapid assessment on ‘Renal denervation systems for treatment-resistant hypertension’
The purpose of the assessment is to assess the effectiveness and safety of renal denervation systems for patients who suffer from treatment-resistant hypertension compared to standard of care (no treatment, additional pharmacological treatment, device-based hypertension therapy and sham treatment). Final version of the assessment was published in December 2013 Below is the documentation provided by […]
Final Project Plan on the second pilot rapid assessment on “Renal denervation systems for treatment-resistant hypertension”
Find the final project plan attached at the bottom of this page. Find the full second pilot assessment here. You can also find the summary document of comments and authors’ replies of the review of the 2nd draft version of the pilot assessment here. WP5 Strand B_2nd pilot_Project Plan
1st pilot rapid assessment of WP5 JA2 Strand B on “Duodenal-jejunal bypass sleeve for the treatment of obesity with or without Type II Diabetes Mellitus”
The purpose of the assessment is to examine the effectiveness and safety of the duodenal-jejunal bypass sleeve/EndoBarrier® in in adults aged 18 years or older with grade II or III obesity (with comorbidities) and/or type 2 diabetes mellitus (+ obesity ≥ grade I) who are not adequately controlled with medication (oral and/or insulin) and lifestyle […]
National report based on pilot assessment of a vaccine using the HTA Core Model® published
LBI, (Ludwig Boltzmann Institute for Health Technology Assessment) Austria, has published a national report based on a EUnetHTA pilot rapid assessment of the herpes zoster vaccine, Zostavax®. Since 2006, a vaccine against Herpes Zoster (Zostavax®) has been licensed for people over 50 years of age. A systematic pilot rapid relative effectiveness assessment of the vaccine […]
Public consultation response to WP5 Strand B’s draft project plan
Public Consultation replies_from_authors_for publication.pdf
1st pilot rapid assessment of WP5 JA2 Strand B on “Duodenal-jejunal bypass sleeve for the treatment of obesity with or without Type II Diabetes Mellitus”
The purpose of the assessment is to examine the effectiveness and safety of the duodenal-jejunal bypass sleeve/EndoBarrier® in in adults aged 18 years or older with grade II or III obesity (with comorbidities) and/or type 2 diabetes mellitus (+ obesity ≥ grade I) who are not adequately controlled with medication (oral and/or insulin) and lifestyle […]
